Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q4 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.